TCGX Acquisition Corp. TCGX
10.04 USD +0.01 (+0.10%)
At closeNov 4, 2026, 4:00 PM EST
10.08 +0.04 +0.40%
After hours · Nov 4, 4:00 PM ET
10.02 Day range 10.05
9.90 52-week range 18.91
- YTD
- +0.40%
- 1 year
- +0.40%
- Market cap
- 99.14M
- YTD return
- +0.40%
- 1-year return
- +0.40%
- Volume
- 54.11K
- Avg volume
- 130.34K
- Open
- 10.05
- Previous close
- 10.03
- Day's range
- 10.02 – 10.05
- 52-week range
- 9.90 – 18.91
2Y +0.03 (+0.30%)
Financials — quick view
TCGX Revenue — quarterly 0
TCGX Net income — quarterly -67.61K
TCGX EPS — quarterly -0.04
News
TriGemX Bio And TCGX Acquisition File Form S-4; Expect To Close Combination In Q1 2027 And Trade On Nasdaq Under Ticker Symbol 'TGEM' 
TriGemX Bio and TCGX Acquisition Corp. Announce Confidential Submission of Draft Registration Statement on Form S-4 in Connection with Proposed Business Combination 
TriGemX Bio To Go Public Through Merger With TCGX Acquisition, Plans Nasdaq Listing Under TGEM; Upon Closing, Combined Company Expected to Receive ~$246M Of Gross Proceeds 
TriGemX Bio and TCGX Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Company to Develop Elismetrep, a Potential First-in-Class Treatment for Migraine
Your note
Sign in to keep a note on TCGX — it syncs with the Stock Master app.